NANOG and leukemia: In particular, bta-miR-150-5p, an important tumor suppresser of leukemia/lymphoma that targets Nanog (a homeobox transcription regulatory factor involved in stem cell pluripotency) [36, 112], had a strong negative correlation with AS1 mRNA expression.